Remy Gressin

5PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag

|Nov 20, 2024
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study.

Adam Mainguy, Carole Soussain, Valérie Touitou

|Apr 04, 2023
The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity.

Fabienne Desmots, Delphine Rossille, Mikael Roussel

|Apr 15, 2022
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.

Laurence Schenone, Caroline Houillier, Marie Laure Tanguy

|Feb 12, 2022
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study.

Domitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne

Pageof 1

Frequent Collaborators

5 joint publications

Ghandi Damaj

3 joint publications

Catherine Thieblemont

2 joint publications

Carole Soussain

2 joint publications

Denis Malaise